There is some good research showing that the use of psychedelics may be beneficial in combination with psychotherapy for treating PSTD, but more research and more comprehensive data are needed before fully implementing them as a viable option.
Sheila Rauch, PhD is the deputy director of the Emory Healthcare Veterans Program.
For information about treatments for PTSD visit The Treatment Hub.
As far as the use of psychedelics in the treatment of PTSD, I think there’s a lot of good research that’s going on. We’re involved in some of that research as well. That is suggesting that it may be helpful for post-traumatic stress disorder, especially potentially in combination with psychotherapy. What I would say is I want good research to continue and for us to get the data so that we know if this is something that’s going to augment the treatments that we already offer for PTSD and to potentially work better for a certain group of patients or work better across the board, potentially make it work faster. All of those are options, but we need to get the results before we’re able to say exactly how to best use psychedelics in the treatment of PTSD. BrainLine is powered in part by Wounded Warrior Project to honor and empower post-9/11 injured service members, veterans, and their families.
Sheila A.M. Rauch, PhD, ABPP, is the Deputy Director of the Emory Healthcare Veterans Program and Director of Mental Health Research and Program Evaluation at the VA Atlanta Healthcare System. Dr. Rauch has been developing programs, conducting research and providing PTSD and Anxiety Disorders treatment for over 20 years. Her research focuses on examination of mechanisms involved in the development and treatment of PTSD and improving access to effective interventions.